| __timestamp | Intra-Cellular Therapies, Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 79435000 |
| Thursday, January 1, 2015 | 87718074 | 162644000 |
| Friday, January 1, 2016 | 93831530 | 237939000 |
| Sunday, January 1, 2017 | 79419009 | 168435000 |
| Monday, January 1, 2018 | 132166913 | 173797000 |
| Tuesday, January 1, 2019 | 89124838 | 113842000 |
| Wednesday, January 1, 2020 | 65782137 | 747027000 |
| Friday, January 1, 2021 | 88845513 | 2534508000 |
| Saturday, January 1, 2022 | 134715000 | 1235278000 |
| Sunday, January 1, 2023 | 180142000 | 737502000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Novavax, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Novavax's R&D expenses surged by over 900%, peaking in 2021 with a staggering $2.5 billion, driven by their COVID-19 vaccine development. In contrast, Intra-Cellular Therapies maintained a steady growth, with a 750% increase, reaching its highest in 2023. This divergence highlights Novavax's aggressive push in response to global health demands, while Intra-Cellular Therapies focuses on sustained innovation in mental health treatments. As the biotech landscape evolves, these spending patterns offer insights into each company's strategic priorities and potential future breakthroughs.
Analyzing R&D Budgets: Amgen Inc. vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Novavax, Inc.
Intra-Cellular Therapies, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Vericel Corporation: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Intra-Cellular Therapies, Inc. and Travere Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: Halozyme Therapeutics, Inc. vs Novavax, Inc.
R&D Spending Showdown: Verona Pharma plc vs Novavax, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Novavax, Inc. Allocate Funds
Soleno Therapeutics, Inc. vs Novavax, Inc.: Strategic Focus on R&D Spending